Eden Research plc
EDNSF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $1 | $2 | $2 | $2 |
| % Growth | -50.4% | 28.1% | -8% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $1 |
| Gross Profit | $0 | $1 | $1 | $1 |
| % Margin | 13% | 52.9% | 31.5% | 65.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2 | $2 | $2 | $2 |
| SG&A Expenses | $2 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | -$0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $2 | $2 | $2 |
| Operating Income | -$2 | -$1 | -$1 | -$1 |
| % Margin | -190.5% | -35.3% | -70.7% | -32.4% |
| Other Income/Exp. Net | -$0 | -$0 | $0 | -$0 |
| Pre-Tax Income | -$2 | -$1 | -$1 | -$1 |
| Tax Expense | -$0 | $0 | -$0 | $0 |
| Net Income | -$2 | -$1 | -$1 | -$1 |
| % Margin | -155.7% | -41% | -48.6% | -29.6% |
| EPS | -0.003 | -0.002 | -0.002 | -0.001 |
| % Growth | -31.6% | -11.8% | -30.8% | – |
| EPS Diluted | -0.003 | -0.002 | -0.002 | -0.001 |
| Weighted Avg Shares Out | 533 | 526 | 534 | 461 |
| Weighted Avg Shares Out Dil | 533 | 533 | 533 | 461 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $0 | $0 | $0 |
| EBITDA | -$2 | -$1 | -$1 | -$1 |
| % Margin | -132.5% | -31.8% | -64.6% | -29.1% |